Inventiva Competitors
| IVA Stock | USD 5.91 0.25 4.06% |
Inventiva vs Enanta Pharmaceuticals Correlation
Good diversification
The correlation between Inventiva Sa and ENTA is -0.09 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Inventiva Sa and ENTA in the same portfolio, assuming nothing else is changed.
Moving together with Inventiva Stock
Moving against Inventiva Stock
At present, Inventiva's Return On Capital Employed is projected to increase significantly based on the last few years of reporting. The current year's Return On Equity is expected to grow to 1.63, whereas Return On Tangible Assets are projected to grow to (1.69). At present, Inventiva's Debt To Assets are projected to increase slightly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 2.78, whereas Total Assets are forecasted to decline to about 95.9 M.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Inventiva's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Inventiva Competition Correlation Matrix
Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Inventiva and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Inventiva and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Inventiva Sa does not affect the price movement of the other competitor.
High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Inventiva Stock performing well and Inventiva Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Inventiva's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| OBIO | 3.77 | (0.16) | 0.00 | (0.04) | 0.00 | 10.17 | 19.34 | |||
| CRBU | 3.07 | (0.87) | 0.00 | (0.25) | 0.00 | 6.86 | 20.16 | |||
| TNYA | 4.88 | (0.98) | 0.00 | (0.24) | 0.00 | 10.57 | 51.79 | |||
| RNAC | 3.50 | (0.30) | 0.00 | (0.90) | 0.00 | 7.26 | 28.90 | |||
| NAUT | 5.06 | 0.84 | 0.13 | (1.10) | 4.82 | 9.93 | 53.15 | |||
| IVVD | 5.01 | (0.07) | 0.00 | (0.46) | 0.00 | 11.11 | 46.37 | |||
| EPRX | 3.05 | 0.65 | 0.20 | 0.49 | 2.82 | 6.98 | 24.61 | |||
| AVTX | 3.39 | (0.19) | 0.00 | (0.91) | 0.00 | 6.64 | 23.40 | |||
| GNFT | 3.17 | 0.66 | 0.12 | (1.38) | 3.86 | 7.34 | 25.18 | |||
| ENTA | 2.45 | 0.34 | 0.11 | 1.88 | 2.61 | 5.67 | 15.79 |
Cross Equities Net Income Analysis
Compare Inventiva Sa and related stocks such as Orchestra BioMed Holdings, Caribou Biosciences, and Tenaya Therapeutics Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OBIO | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (21.4 M) | (23 M) | (33.6 M) | (49.1 M) | (61 M) | (54.9 M) | (57.7 M) |
| CRBU | (23.4 M) | (23.4 M) | (23.4 M) | (23.4 M) | (23.4 M) | (23.4 M) | (23.4 M) | (23.4 M) | (23.4 M) | (23.4 M) | (34.3 M) | (66.9 M) | (99.4 M) | (102.1 M) | (149.1 M) | (134.2 M) | (127.5 M) |
| TNYA | (25.8 M) | (25.8 M) | (25.8 M) | (25.8 M) | (25.8 M) | (25.8 M) | (25.8 M) | (25.8 M) | (25.8 M) | (25.8 M) | (38.4 M) | (69.7 M) | (123.7 M) | (124.1 M) | (111.1 M) | (100 M) | (105 M) |
| RNAC | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (12.9 M) | (25.2 M) | (36.2 M) | (65.3 M) | (65.3 M) | (55.4 M) | (68.9 M) | (25.7 M) | 35.4 M | (219.7 M) | (77.4 M) | (69.7 M) | (73.2 M) |
| NAUT | 626.6 M | 626.6 M | 626.6 M | 626.6 M | 626.6 M | 626.6 M | 626.6 M | 626.6 M | 626.6 M | (9.6 M) | (15.6 M) | (50.3 M) | (57.9 M) | (63.7 M) | (70.8 M) | (63.7 M) | (60.5 M) |
| IVVD | (112 M) | (112 M) | (112 M) | (112 M) | (112 M) | (112 M) | (112 M) | (112 M) | (112 M) | (112 M) | (112 M) | (226.8 M) | (241.3 M) | (198.6 M) | (169.9 M) | (152.9 M) | (160.6 M) |
| EPRX | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (4.4 M) | (13.2 M) | (7.4 M) | (4 M) | (18 M) | (18.5 M) | (28.2 M) | (36.7 M) | (33 M) | (31.4 M) |
| AVTX | (10.5 M) | (10.5 M) | (10.5 M) | (13 M) | (16.1 M) | (10.5 M) | (16.5 M) | 11.9 M | (40.1 M) | (16.1 M) | (63.5 M) | (84.4 M) | (41.7 M) | (31.5 M) | (35.1 M) | (31.6 M) | (33.2 M) |
| GNFT | 2.2 M | (9.7 M) | (5.4 M) | (12.7 M) | (17 M) | (17.1 M) | (33.7 M) | (58.6 M) | (79.5 M) | (65.1 M) | (101.2 M) | 67.3 M | (23.7 M) | (28.9 M) | 1.5 M | 1.4 M | 1.4 M |
| ENTA | 7.9 M | 21.4 M | 9.6 M | 34.4 M | 79 M | 21.7 M | 17.7 M | 72 M | 46.4 M | (36.2 M) | (79 M) | (121.8 M) | (133.8 M) | (116 M) | (81.9 M) | (73.7 M) | (70 M) |
Inventiva Sa and related stocks such as Orchestra BioMed Holdings, Caribou Biosciences, and Tenaya Therapeutics Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Inventiva Sa financial statement analysis. It represents the amount of money remaining after all of Inventiva Sa operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Inventiva Competitive Analysis
The better you understand Inventiva competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Inventiva's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Inventiva's competition over several years is one of the best ways to analyze its investment potential.| Better Than Average | Worse Than Peers | View Performance Chart |
Inventiva Competition Performance Charts
Five steps to successful analysis of Inventiva Competition
Inventiva's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Inventiva Sa in relation to its competition. Inventiva's competition analysis typically involves several steps, including:- Identifying the key players in the market: This involves identifying the major competitors of Inventiva in the market, both direct and indirect, as well as new entrants and disruptive technologies.
- Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
- Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Inventiva's competitive landscape.
- Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Inventiva Sa, and developing a strategy to address them.
- Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Complement your Inventiva position
In addition to having Inventiva in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Electronics Thematic Idea Now
Electronics
Companies manufacturing electronic appliances and goods. The Electronics theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronics Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Inventiva Correlation with its peers. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inventiva. Market participants price Inventiva higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Inventiva assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.36) | Revenue Per Share | Quarterly Revenue Growth 1.052 | Return On Assets | Return On Equity |
Understanding Inventiva Sa requires distinguishing between market price and book value, where the latter reflects Inventiva's accounting equity. The concept of intrinsic value—what Inventiva's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Inventiva's price substantially above or below its fundamental value.
Please note, there is a significant difference between Inventiva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inventiva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Inventiva's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.